JUMP REPORT
TILRAY (TLRY)
EARNINGS RELEASE - AUGUST 10 (AMC)
EARNINGS EXPECTATIONS:
THIS QTR: EPS: -.27/share REV: 55.02/M
___________________________________________________________
LAST QTR: EPS: -.45/share ACTUAL: -1.73/share (MISS)
____________________________________________________________
NEXT QTR: EPS: -.24/share REV: 60.15/M
____________________________________________________________
FULL YR: EPS: -2.27/share REV: 237.68/M
____________________________________________________________
BEAT/MISS RECORD: 14% OF THE TIME THEY BEAT ESTIMATES
PRIOR ‘JUMP ZONE’ MOVES (LAST 3 QTRS %) -8.66, -15.3, -3.01
EXPECTED JUMP MOVE THIS QUARTER: 10-12%
——–
*** With market volatility at extremes there is greater risk in trading these events which may not react as they would under normal market conditions. Please take extra caution before tradin
Links To Latest News and Headlines
The cannabis industry is experiencing rapid growth. According to Allied Market Research, if estimates are correct, it could be worth $149 billion by 2031. While Canadian pot stocks have a legal market to grow in, the market is modest compared to the U.S. Meanwhile, U.S. cannabis stocks continue to defy expectations even in a limited state market.
Tilray Brands, Inc. (TLRY) closed the most recent trading day at $3.85, moving +1.85% from the previous trading session.
Billionaire investor Warren Buffett has been invested in stocks for decades, and has seen many presidents come and go during that time. You don’t need to get in and out of stocks depending on election results or changes in power. Buffett hasn’t let that affect his long-term strategy, and investors would do well to follow a similar approach.
Yahoo Finance’s Jared Blikre is joined by Surgeon, Entrepreneur, Financial Literacy Enthusiast, as they discuss bigger picture issues, take on crypto, and more.
Given that the industry-tracking AdvisorShares Pure US Cannabis ETF (NYSEMKT: MSOS) is down by more than 60% in the last 12 months, dramatically underperforming the broader market’s slump of 14.5%, it’s safe to say that marijuana stock investors are likely feeling a bit down on their luck lately. The biggest change coming to cannabis stocks in the next couple of years is the possible advance of marijuana legalization in the U.S. and in the E.U. While the jury is still out on whether the federal government will legalize adult-use cannabis anytime soon, enterprising state legislatures are already forging ahead. While there’s no timeline for when recreational sales will begin, Tilray Brands (NASDAQ: TLRY) is likely the best positioned to benefit since it’s currently serving the country’s medical cannabis market.
StockJumpers analysis and trade plans are finalized and uploaded generally one house before market cloase (3PM EST) for most events unless noticed.
“I’m sorry, this content is for members only. To access this content, you must log in with your membership credentials – OR if you are not a member yet, visit our registration page here and get signed up Looking forward to having you on-board ASAP”
There is a significant amount of data behind the scenes involved in the analysis and trade plan tab above, that does not get put into the report. Too much information for traders often confuses things – so this is stripped down to only what is needed to make the best possible decision(s) on trading the trajectory.
Members who are too busy to manual trade can use Trade Assist. For more information visit here
| Avg Daily Volume: 9,055,059 Market Cap: 946.45M Sector: Consumer Durables Short Interest: 19.43 |
Ticker delayed 20 minutes
NOTICE: All material on this site has been published for informational and educational purposes only and does not constitute an offer to sell nor a solicitation of an offer to buy any security which may be referenced here or in our websites. StockJumpers is not an Investment Adviser and relies on the publisher’s exemption as defined in Section 401(f) of the Uniform Securities Act, and provides no personal advice or recommendations. The services and published information contained herein is for non-commercial, educational use and display. StockJumpers and any of its affiliates does not represent that the securities or services discussed are suitable for any investor. You should assume that StockJumpers and or its management has or will take a position in the stock, whether it is stated or not. You are further advised not to rely on any information contained in this report and associated websites in the process of making a fully informed investment decision. Trading is risky and you can lose your investment. For the complete risk disclosure and other legal information please review the full Terms of Use Agreement.
by Team Stockjumpers